Fennec Pharmaceuticals (FENC) Non-Current Debt (2021 - 2022)

Fennec Pharmaceuticals (FENC) has 2 years of Non-Current Debt data on file, last reported at $25.0 million in Q3 2022.

• Quarterly Non-Current Debt changed N/A year-over-year to $25.0 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $25.0 million (changed N/A YoY) and the FY2021 annual result came in at $5.0 million, changed N/A from the prior year.
• Non-Current Debt rose to $25.0 million in Q3 2022, from $4.0 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $25.0 million in Q3 2022 to a low of $4.0 million in Q2 2022.